Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheets (Unaudited)

v3.22.2
Consolidated Balance Sheets (Unaudited) - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 19,549 $ 29,972
Restricted cash 0 203
Accounts receivable, less allowance of $2,286 and $2,154 as of June 30, 2022 and December 31, 2021, respectively 6,081 4,238
Inventory 16,573 12,929
Prepaid expenses and other current assets 2,064 2,012
Total current assets 44,267 49,354
Property, plant, and equipment, net 1,373 1,067
Goodwill 2,926 2,926
Right of use asset 2,047 1,717
Other assets 241 220
Total assets 50,854 55,284
Current liabilities:    
Accounts payable 4,961 3,309
Accrued liabilities 6,498 8,276
Deferred revenue, current portion 2,492 2,259
Total current liabilities 13,951 13,844
Deferred revenue 325 329
Warranty accrual 431 521
Non current term loans, net of discount 12,730 13,603
Non current operating lease liability 1,592 1,449
Other liabilities 210 330
Total liabilities 29,239 30,076
Commitments and contingencies — Note 11
Stockholders' equity:    
Series F Preferred stock, par value $0.001 per share; 18 shares authorized, 0 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 0 34
Common stock, par value $0.001 per share; 180,000 shares authorized, 6,857 and 6,149 shares issued and 6,855 and 6,147 shares outstanding as of June 30, 2022 and December 31, 2021, respectively 7 6
Additional paid-in-capital 300,414 293,325
Accumulated other comprehensive loss (886) (623)
Accumulated deficit (277,920) (267,534)
Total stockholders' equity 21,615 25,208
Total liabilities, redeemable preferred stock and stockholders' equity $ 50,854 $ 55,284